Loading organizations...
Yuanhe Capital operates as an investment firm focused on early-stage entrepreneurial innovation, venture, and growth opportunities. The firm primarily functions as a fund of funds and an angel fund, advising on capital deployment across various stages of technology-driven enterprises. Its investment strategy encompasses a diversified range of opportunities within the technology sector.
Established in 2019, Yuanhe Capital was co-founded by Wu Yaoxuan and Zhang Zhengxi. Their vision for the firm emerged from an understanding of the evolving landscape for early-stage and growth-oriented technology companies, aiming to provide strategic capital and advisory services to foster innovation and expansion.
The firm serves entrepreneurs and various fund managers seeking strategic investment and growth capital, particularly within the technology domain. Yuanhe Capital's long-term vision centers on identifying and supporting high-potential ventures, thereby contributing to the development and acceleration of innovative technologies across diverse industries.
Yuanhe Capital has 2 tracked investments across 2 companies. The latest tracked deal is $14.3M Other Equity in KEYi Tech in January 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 7, 2026 | KEYi Tech | $14.3M Other Equity | Wuzhong Financial Holdings, Yuanhe Capital | — |
| Sep 8, 2023 | GRIT Biotechnology | $60.0M Series B | CICC Capital | Decheng Capital, Hefangtian Venture Partnership, Liando Investment, Matrix Partners China, Sherpa Healthcare Partners |
